Announcement on the Voluntary Disclosure of the Inclusion of Deutenzalutamide Soft Capsules in the 2025 National Medical Insurance Drug Catalog

About this update from Hinova Pharmaceuticals, Inc. Class A

Announcement on the Voluntary Disclosure of the Inclusion of Deutenzalutamide Soft Capsules in the 2025 National Medical Insurance Drug Catalog The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hinova Pharmaceuticals, Inc. Class A